Clinical Trial Update: Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ixabepilone with hydroxychloroquine in metastatic breast cancer; phases 1 and 2, terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Ixabepilone (ixabepilone)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-12-25